[1]
Hussein, R.G. and Al-Atrakji, M.Q. 2024. Impact of Infliximab Biosimilar (Ixifi®) Trough Levels on Disease Activity and Inflammatory Markers in Iraqi Rheumatoid Arthritis Patients. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 7, 1(Special) (Sep. 2024), S36–40. DOI:https://doi.org/10.54133/ajms.v7i1(Special).906.